Metabomed

Developer of targeted therapies to treat cancer

placeYavne, Center District, Israel calendar_todayFounded 2013 groups7 employees language metabomed.com

Innovation

4 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 227 times.

YearFilings
20191
20202
20213
20223
20233
20242
20251

Investor mix

8 investors on record; lead investors include Yonjin Capital.

Investor typeCountShare
Venture capital788%
Other / undisclosed113%
Coming soon